Live Breaking News & Updates on Agency Seeking Approval Of Lazertinib

Stay updated with breaking news from Agency seeking approval of lazertinib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Johnson & Johnson : Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Lazertinib, in combination with RYBREVANT®▼ (amivantamab), for the First-Line Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer -December 21, 2023 at 08:44 am EST

News Release

Media Contacts:

Zayn Qureshi

+44 7760 334666 Email: zqureshi@its.jnj.com

Investor. ....

Region Flamande , United States , Catherine Taylor , Kiran Patel , Zayn Qureshi , Janssen Research Development , Janssen Biotech Inc , European Union , Janssen Pharmaceutical Companies Of Johnson , Clinical Development , National Cancer Institute , American Lung Association , European Society Of Medical Oncology , Janssen Research , European Medicines Agency , Cilag Gmbh International , Agency Seeking Approval Of Lazertinib , European Commission , Exchange Commission , European Society For Medical Oncology , Companies Of Johnson , Yuhan Corporation , News Release , Submits Marketing Authorisation Application , European Medicines , Seeking Approval ,